Labisan vs Compeed for Cold Sores: Honest Side-by-Side Comparison

Compeed Cold Sore Patch is the European market leader for active cold sore management. Labisan Protective Lip Balm is a multi-active antiviral with SPF 20 designed for prevention and ongoing support. The two products solve different parts of the same problem and the honest answer for most users is to use both, not to pick a winner. This comparison lays out the mechanisms, the use cases each one wins, the ones each one loses, and the verdict at the end.

Before going deeper, the simple framing: Compeed is a hydrocolloid patch that physically covers a visible lesion. Labisan is a topical balm with antiviral actives plus mineral UV protection. Mechanism (barrier vs antiviral chemistry), timing (during a visible outbreak vs every day), and ideal user (someone with an active sore right now vs someone who wants fewer outbreaks per year) are all different.

What Compeed Actually Is

Compeed Cold Sore Patch is a small, translucent hydrocolloid dressing engineered to adhere to the lip area for up to 12 hours. Hydrocolloid technology is borrowed from chronic-wound care; the gel-forming polymers absorb fluid from the lesion, maintain a moist healing environment, and provide a physical barrier between the sore and the outside world. Compeed does not contain an antiviral compound. It does not act on viral replication. Its mechanism is purely physical: cover the lesion, absorb exudate, support a moist wound bed, and reduce visible appearance and transmission risk.

Compeed sells discretion. The patch is thin, translucent, and stays put through eating, drinking, and even mild exercise. For someone who has a fully visible vesicle or scab and a meeting in two hours, Compeed solves the immediate social problem in a way no balm can.

What Labisan Protective Lip Balm Actually Is

Labisan Protective Lip Balm is a five-active topical formula with 22 percent non-nano zinc oxide for SPF 20 and antiviral drying, 5 percent graviola fruit extract, manuka oil (rich in beta-triketones), oregano oil (carvacrol and thymol), and menthol. The supporting layer adds astaxanthin, vitamin E, and allantoin in a shea butter, cocoa butter, and almond oil base. The full ingredient breakdown is in the formula post.

Labisan acts on viral replication through multiple parallel mechanisms (envelope disruption from manuka and oregano, mitochondrial Complex I modulation from graviola acetogenins, mechanical drying from zinc oxide), provides daily UV protection (one of the most common cold sore triggers), and works as a daily prevention layer rather than a single-outbreak intervention. It is not a patch. It does not cover the lesion physically. It is a balm you apply four times per day during waking hours.

Where Compeed Wins

Compeed wins on the visible-lesion problem. If you have a cluster of vesicles or a forming scab and you need to be in a client meeting, on a date, or on camera in the next few hours, Compeed will physically cover the lesion in a way that nothing else in this category does. The translucent patch is genuinely discreet, especially at conversational distance.

Compeed also wins on transmission risk during the active phase. The hydrocolloid layer creates a physical barrier between the lesion and external skin, cutlery, glasses, and partners. This is real, documented infection-control benefit that a topical balm cannot replicate by itself.

Compeed wins on scab protection. Once the vesicle has consolidated into a scab, the patch protects it from accidental knocks, friction from food and drink, and unconscious touching, all of which are the typical reasons a scab gets reopened and the healing timeline gets reset. The hydrocolloid environment also keeps the wound bed moist, which is favourable for clean healing without deep cracking.

Compeed wins on availability. Most European pharmacies stock it. It costs roughly 8 to 12 euros for a pack, and a single patch can run for half a day. For an emergency, walk-in convenience matters.

Where Labisan Wins

Labisan wins on prevention. Compeed has nothing to apply before a lesion is visible. Once the vesicle is forming, you have already lost the prevention window. Labisan's daily SPF 20 plus zinc oxide plus multi-active antiviral layer is designed to apply every day in the lifestyle conditions that trigger HSV reactivation (alpine UV, cold dry wind, beach sun, post-flight stress). Reducing trigger exposure is the only way to actually reduce the number of outbreaks per year.

Labisan wins on multi-active antiviral coverage. The five topical actives address viral replication through different mechanisms simultaneously, so the protocol is not dependent on a single mode of action. Compeed has zero antiviral compounds; it relies on the body to clear the virus while it provides physical cover.

Labisan wins on daily-use compatibility. You can apply it before a ski day, reapply every 90 minutes following the 90 minute rule, and integrate it into your normal lip care routine without anyone noticing. Compeed patches are visible up close, fall off in heavy sweat or extended water exposure, and are not designed for continuous use.

Labisan wins on the prevention-plus-recovery integration. The same balm that prevents UV-triggered outbreaks also supports recovery during an active outbreak when applied four times daily, as documented in the four-case timeline post. You buy one product that handles two phases of the outbreak cycle.

Labisan wins on the systemic dual-protocol option. Pair the lip balm with the 22:1 Graviola Fruit Capsules and you get an immune-support layer that Compeed cannot offer because it is a dressing, not a supplement system.

The Mechanism Difference Matters

A hydrocolloid patch and an antiviral balm are not in the same product category, even though both market to the same cold sore search query. Compeed is a wound dressing optimised for one specific situation: an already-visible lesion that needs covering and a moist healing environment. Labisan is a topical-pharmaceutical-grade prevention and recovery balm with an active antiviral chemistry plus daily UV defence.

Comparing them head-to-head on a single timeline is misleading because they are answering different questions. The right question is not "which one heals a cold sore faster" but "what stage of the cycle am I in, and what does the right intervention for that stage look like."

The Combined Protocol: How Most Users Should Actually Use Both

For users with a recurring cold sore pattern, the highest-value approach combines both products at different points in the cycle. Use Labisan as the daily layer for prevention, particularly during high-trigger windows (ski trips, beach holidays, long flights, intense work stress). When a lesion does break through and reaches the visible vesicle stage, add Compeed during waking hours when discretion or transmission control matters, and continue applying Labisan to the surrounding lip border and during sleep when the patch is off. Add the graviola capsules systemically during the outbreak window for the immune-support layer.

This combined protocol uses each product for what it does best: Compeed for the four to six hour public-visibility window, Labisan for everything else.

Honest Verdict

If you are looking for a single product to cover an actively visible cold sore for the next few hours and you need to be in public, Compeed is the right choice. If you are looking for a system that reduces how often you get cold sores in the first place, supports recovery when one does break through, and provides daily UV protection (since UV is one of the most common reactivation triggers), Labisan is the right choice. Most users with recurring HSV-1 are best served by owning both: Compeed for the visible-lesion days, Labisan for every other day of the year. The two products complement each other; they do not compete.

Frequently Asked Questions

Can I apply Labisan over a Compeed patch?

No, the hydrocolloid patch needs direct skin contact to adhere and to maintain its moist wound environment. Apply Labisan to the surrounding lip border and the rest of the lip area, then apply Compeed only over the visible lesion. Remove the patch before sleep and apply Labisan over the whole area overnight.

Does Compeed prevent future cold sores?

No. Compeed is a wound dressing, not a prevention product. It only works once a lesion is already visible. To reduce the frequency of future outbreaks, you need to address the trigger pattern (UV exposure, stress, sleep debt) and ideally add a daily antiviral prevention layer like Labisan plus systemic immune support like the graviola capsules.

Is the SPF in Labisan enough for ski conditions?

SPF 20 with 22 percent non-nano zinc oxide is the formulation team's calibrated balance of UV protection and reapplication frequency. At altitude, where UV index is roughly 30 percent higher than at sea level, the 90 minute reapplication cadence becomes essential rather than optional. See the 90 minute rule post for the math.

Does Compeed actually shorten cold sore duration?

Manufacturer trials report visible-lesion duration reductions in the range of one to two days versus untreated outbreaks, primarily attributed to the moist wound environment and reduced reopening of the scab through accidental knocks. The benefit is real but modest; it is not an antiviral effect. The patch does not act on viral replication.

Can I use Labisan during an active outbreak with no Compeed?

Yes. The Labisan four-applications-per-day topical protocol plus the elevated graviola dose during the outbreak window is the documented dual protocol described in the 48 hour protocol post. Compeed is optional; it adds physical cover and transmission control but is not required for the antiviral action.

Which is better value over a year?

For someone with three to four cold sores per year, Compeed is cheaper per outbreak (one pack covers most outbreaks) but has zero prevention value. Labisan has higher upfront cost but works year-round on the prevention side. For users who currently get four or more outbreaks per year, the prevention math typically favours Labisan because reducing outbreak frequency by even one or two events per year covers the cost differential.